Cargando…

Use of anti-TNF Etanercept in paediatric patients with autoimmune disease and ocular involvement: the Parma experience

Detalles Bibliográficos
Autores principales:	Rossi, M, Gonzales, S, Orsoni, J, Zavota, L, De Fanti, A, Izzi, GC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333942/ http://dx.doi.org/10.1186/1546-0096-6-S1-P144

Ejemplares similares

Incidence of Ocular Zoonoses referred to the Inflammatory and Autoimmune Ocular Diseases Service of the University of Parma - Italy
por: Gonzales, Stefania, et al.
Publicado: (2009)

DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
por: Vojinovic, J, et al.
Publicado: (2008)

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
por: Henry, Alistair I, et al.
Publicado: (2011)

Influence of TNFα–308 and T676G TNF-RII polymorphism on response to etanercept and posibility to discontinue tretment
por: Vojinovic, J, et al.
Publicado: (2011)

Staphylococcus aureus and autoimmune uveitis reactivation in childhood: a possible correlation?
por: Mora, Paolo, et al.
Publicado: (2009)

Etanercept discontinuation in a cohort of juvenile idiopathic arthritis patients: etanercept inefficacy but not intolerance is associated with oral corticosteroid use
por: Southwood, TR, et al.
Publicado: (2008)

The role of etanercept in juvenile dermatomyositis (JDMS) in children
por: Green, Katherine L, et al.
Publicado: (2014)

The charterhouse of Parma /
por: Stendhal, 1783-1842
Publicado: (1953)

Etanercept efficacy in the treatment of chronic isolated inflammatory coxitis
por: Parodi, A, et al.
Publicado: (2008)

Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis
por: Lazareva, Arina, et al.
Publicado: (2011)

Long-term efficacy of etanercept in ADA2 deficiency
por: Caorsi, Roberta, et al.
Publicado: (2014)

Multicentric Castleman's Disease (CD) in juvenile idiopathic arthritis (JIA) treated with etanercept: coincidence or causal relationship?
por: Rossi, L, et al.
Publicado: (2008)

Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
por: Rexhepi, Sylejman, et al.
Publicado: (2012)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2011)

Monitoring of anti-TNF biological treatments
por: Ruiz del Agua, A, et al.
Publicado: (2010)

LEP Parma Meeting
Publicado: (1988)

A case of chronic recurrent multifocal osteomyelýtýs successfully treated with etanercept
por: Aktay Ayaz, N, et al.
Publicado: (2008)

Etanercept therapy in JIA: impact on the need for intra-articular steroid injections
por: Pain, CE, et al.
Publicado: (2008)

Etanercept improves pro-atherosclerotic biomarkers in children with juvenile idiopatic arthritis
por: Sara, De Sanctis, et al.
Publicado: (2011)

DNase I levels and disease outcome in JIA patients treated with etanercept
por: Lazarević, D, et al.
Publicado: (2011)

Serum tumor necrosis factor alpha increased during remission with Etanercept
por: Spirchez, Mihaela, et al.
Publicado: (2011)

The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
por: Alfantaki, SA, et al.
Publicado: (2011)

Discontinuation of etanercept after clinical remission in patients with juvenile idiopathic arthritis
por: Cohen, Jean-David, et al.
Publicado: (2012)

Imaging of refractory chronic recurrent multifocal osteomyelitis succesfully treated with etanercept and methotrexate
por: Quesada-Masachs, Estefania, et al.
Publicado: (2014)

Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2012)

Predictors of response and anti-TNF drugs comparative efficacy
por: Canhão, Helena, et al.
Publicado: (2011)

Mitogen-activated kinases in psoriatic arthritis: differences in activation and distinct regulation by etanercept therapy
por: Lories, RJU, et al.
Publicado: (2005)

The use of Etanercept and Adalimumab in the management of JIA: a 5-year follow-up study
por: Trachana, M, et al.
Publicado: (2008)

When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis
por: Prince, FHM, et al.
Publicado: (2008)

The impact of a 2-year Etanercept administration on growth of patients with juvenile idiopathic arthritis
por: Trachana, M, et al.
Publicado: (2011)

In vitro effects of etanercept on the development of different T cell subsets in patients with juvenile idiopathic arthritis
por: Cimaz, Rolando, et al.
Publicado: (2011)

Indirect comparison of etanercept and abatacept efficacy and safety in patients with polyarticular juvenile idiopathic arthritis
por: Loskutova (Konopelko), OU, et al.
Publicado: (2014)

Anti-inflammatory effect of rebamipide on the ocular surface
por: Ueta, Mayumi, et al.
Publicado: (2013)

La cartuja de Parma
por: Stendhal, 1783-1842
Publicado: (1968)

La cartuja de Parma
por: Stendhal, 1783-1842
Publicado: (1967)

La cartuja de Parma
por: Stendhal, 1783-1842

La cartuja de Parma
por: Stendhal, 1783-1842

La cartuja de Parma
por: Stendhal, 1783-1842

La cartuja de parma
por: Stendhal, 1783-1842

La cartuja de parma
por: Stendhal, 1783-1842

Cannot write session to /tmp/vufind_sessions/sess_47k8d8bb0ean1e018bhhm3mg24